Clinical Trials
111 trialsPeople With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
National Institutes of Health Clinical Center (CC)
Kirros
Genentech, Inc.
Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis
National Cancer Institute (NCI)
NARFI
University Hospital, Bordeaux
Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant
University of Cincinnati
Extracellular RNA Markers of Liver Disease and Cancer
Mayo Clinic
Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function
M.D. Anderson Cancer Center
PREMIUM
VA Office of Research and Development
VOCAL
Imperial College London
A Study to Assess an ATX Inhibitor (IOA-289) in Patients With Metastatic Pancreatic Cancer
iOnctura
BISHOP
University of Aarhus
FASTRAK
Assistance Publique - Hôpitaux de Paris
Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention
M.D. Anderson Cancer Center
Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury
Massachusetts General Hospital
Active Choice Clinical Decision Support (CDS): Hepatocellular Carcinoma (HCC) Screening in Patients With Cirrhosis
NYU Langone Health
GTI
University of Pittsburgh
LivMOD
Institut National de la Santé Et de la Recherche Médicale, France
OASIS
VA Office of Research and Development
Clinical Management Strategies for Patients With Cirrhosis and Esophagogastric Varices Complicated by Early-stage Upper Gastrointestinal Cancer
Renmin Hospital of Wuhan University
SACRED
VA Office of Research and Development
GREAT1
University of Pittsburgh
Characterization of Focal Liver Lesions by Real-time Contrast-enhanced Ultrasound Imaging (CEUS)
University Hospital, Tours
MUTHEC
Institut National de la Santé Et de la Recherche Médicale, France
ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk
Exact Sciences Corporation
A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer
Inova Health Care Services
Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis
Massachusetts General Hospital
REVISE-HCC
Manchester University NHS Foundation Trust
AMULET
University of Oxford
LIVER-TRACK
Assistance Publique - Hôpitaux de Paris
Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC
Mansoura University
CTMH
Northern Jiangsu People's Hospital
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
Dana-Farber Cancer Institute
Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study
First Affiliated Hospital Xi'an Jiaotong University
Non-invasive Assessment for Outcome Prediction in Patients With Hepatocellular Carcinoma
Chinese University of Hong Kong
Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver Cancer
Northwestern University
MHALT
University of California, San Francisco
SB-1121
Trieu, Nguyen Thi, M.D.
LIVERATION
Can-Fite BioPharma
BIM-LT
University Hospital, Grenoble
VOCAL2
Imperial College London
RCAP
Replicor Inc.
Bariatric Embolization of Arteries in Obese Patients With HCC to Allow Salvage Liver Transplantation
St. Louis University
Cameroon Baptist Convention Health Board Chronic Hepatitis B Cohort Study
Mayo Clinic
SEPT9_SuRV
Central Hospital, Nancy, France
SEPT9-CROSS
Central Hospital, Nancy, France
CHIMIOSE
University Hospital, Lille
STARHE
IHU Strasbourg
Triple Recipient Strategy Using Split, Domino, and Auxiliary Techniques
Second Affiliated Hospital, School of Medicine, Zhejiang University
Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors
National Cancer Institute (NCI)
Prevention of Recurrent Hepatitis B After Liver Transplantation
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)